Nevertheless, three recent large meta-analyses confirmed longer DFS in AR-positive versus AR-negative BC patients23–25 and multiple studies (both single and multicenter case series and prospective studies) have shown AR expression to be significantly associated with lower mitotic index and lower tumor grade at diagnosis15,17,26–28. The gene discussed is AR; the disease is breast cancer.